Latest market price
99.55
+4.12+4.32%
ORKAQT91Oruka Therapeutics, Inc.·NASDAQ
99.55+4.32%

Latest SEC Filings

Form category
DescriptionFilingDocument
Nov 02, 20264Statement of changes in beneficial ownership
Oct 26, 20268-KCurrent report
Oct 20, 20264Statement of changes in beneficial ownership
Oct 15, 20264Statement of changes in beneficial ownership
Oct 13, 20264Statement of changes in beneficial ownership
Oct 02, 20264Statement of changes in beneficial ownership
Sep 21, 2026144Notice of proposed sale of restricted securities
Sep 21, 20264Statement of changes in beneficial ownership
Sep 21, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 15, 20264Statement of changes in beneficial ownership
Sep 01, 2026144Notice of proposed sale of restricted securities
Sep 01, 2026144Notice of proposed sale of restricted securities
Sep 01, 20264Statement of changes in beneficial ownership
Sep 01, 20264Statement of changes in beneficial ownership
Aug 28, 2026424B5Prospectus
Aug 27, 2026EFFECTNotice of effectiveness
Aug 25, 20264Statement of changes in beneficial ownership
Aug 25, 20263Initial statement of beneficial ownership
Aug 24, 20268-KCurrent report
Aug 21, 2026S-3Shelf registration statement
Aug 17, 20264Statement of changes in beneficial ownership